Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer
| Autor: | Asher Barak, Amir Vardi, Gideon Paret, Dalit Modan-Moses, Amos Toren, Ori Efrati, Y. Neumann, Bella Bielorai, Amir Szeinberg, U Gonik |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Lung Diseases Male medicine.medical_specialty Neutropenia Adolescent Biopsy Pneumonia Viral Comorbidity Bronchoscopies Immunocompromised Host Neoplasms Bronchoscopy Pneumonia Bacterial medicine Aspergillosis Fiber Optic Technology Humans Child Retrospective Studies Lung Diseases Fungal medicine.diagnostic_test business.industry Pneumonia Pneumocystis Immunologic Deficiency Syndromes Infant Cancer Retrospective cohort study Hematology medicine.disease Surgery Pneumonia Bronchoscopes Bronchoalveolar lavage Oncology Child Preschool Pediatrics Perinatology and Child Health Primary immunodeficiency Female business Bronchoalveolar Lavage Fluid |
| Zdroj: | Pediatric Blood & Cancer. 48:324-329 |
| ISSN: | 1545-5017 1545-5009 |
| DOI: | 10.1002/pbc.20784 |
| Popis: | Background Patients with childhood cancer or primary immunodeficiencies (PID) are at high risk for developing pulmonary infections and non-infectious complications. The broad differential diagnoses and the critical condition of these patients often drive physicians to start broad-spectrum antibiotic therapy before a definite diagnostic procedure is performed. A definite diagnosis may be achieved in these situations by fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage (BAL). Patients and Methods The records of 58 PIDs and cancer (immunocompromised group) pediatric patients who underwent 62 fiberoptic bronchoscopies between 2000 and 2004 were retrospectively reviewed and compared to 158 non-cancer patients who underwent 182 fiberoptic bronchoscopies during the same period. Results The overall diagnostic rate achieved by macroscopic inspection of purulent secretions or hemorrhage, abnormal cell count, and infectious agent isolation in the immunocompromised patients was 84%. A definite organism was recovered in 53.2% of the patients. Probable infection defined as purulent secretions or abnormal cell count without infectious agent isolation was diagnosed in another 21% of the patients. The rate of complications was 30.6%. In the control group, the overall diagnostic rate was 76.9% (n.s) and an infectious agent was demonstrated in 12.1% (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text